New program offers cancer patients alternative, home-like care setting for stem cell transplant

July 09, 2000

In August 1999, Pastor Robert Duncan had learned his non-Hodgkin's lymphoma was no longer in remission. A friend referred Duncan, 61 and a resident of Westville, Ind., to oncologists at Rush-Presbyterian-St. Luke's Medical Center in Chicago. Rush physicians told him he could receive a stem cell transplant through the hospital's newly established OutPatient Transplantation (OPTion)" program.

Patients, like Duncan, who need a stem cell transplant may qualify to receive their care in this outpatient setting rather than through an expensive inpatient hospital stay that often lasts for two to three weeks.

Patients of the OPTion program stay in an on-campus apartment located just within walking distance of the intensive ambulatory care unit adjacent to Rush's inpatient unit. The three-room apartment is equipped with a kitchen, room to sleep four, and air purifiers to reduce risk of infection in the living room and the bedroom. Rush requires the patients to be accompanied by a caregiver during their stay in the apartment in case of emergency. If complications arise, patients move into the adjacent hospital immediately. Duncan is only the second patient to stay in the apartment through this program.

"Patients can now receive optimal, sophisticated medical care while resting comfortably in a home-like setting," said medical oncologist and director of the Rush Bone Marrow Transplant program Hans Klingemann, MD, PhD. Once it is determined that a stem cell transplant is the best treatment option, the search for a stem cell donor begins. There are two types of donors: allogeneic or a donor other than the patient, or autologous or a self-donor. According to Klingemann, the ideal donor is a same sex sibling. In Duncan's case, his donor was his older brother Harold.

To prepare the body to receive donor stem cells, the recipient undergoes chemotherapy and/or radiation days prior to transplant.

Once the ideal donor is identified, the donor undergoes a four-to-five day process to prepare the donor stem cells for collection. On the day of the transplant the donor undergoes apheresis, the process that separates the stem cells from the rest of the blood's components. This process requires blood to be drawn from the donor then filtered through a machine that isolates the stem cells for infusion into the recipient. The blood's other components are then infused back into the donor.

On that same day of the infusion, the patient receives the donor stem cells through a catheter that is placed in a major vein in the chest. Following this, the patient is monitored and remains in the outpatient apartment for a two-week period, during which the patient is at the highest risk for infection. This less expensive option has patients and payors alike satisfied with the lower costs. "I have received wonderful care from the staff at Rush. Because I have never been hospitalized before, I did not look forward to a two-or three-week hospital stay. The residential quarters provided home-like amenities and made my stay more comfortable," said Duncan.

The Bone Marrow Transplant program at Rush recently received accreditation from the Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT). Rush's bone marrow transplant program is fully accredited for allogeneic and autologous marrow and peripheral blood progenitor cell transplantation, including cell collection and laboratory processing. To date, only 18 transplant centers across the country have received this level of accreditation from this comprehensive standard-setting program.
Rush-Presbyterian-St. Luke's Medical Center includes the 809-bed Presbyterian-St. Luke's Hospital; 154-bed Johnston R. Bowman Health Center for the Elderly; Rush University (Rush Medical College, College of Nursing, College of Health Sciences and Graduate College); and seven Rush Institutes providing diagnosis, treatment and research into leading health problems. The medical center is the tertiary hub of the Rush System for Health, a comprehensive healthcare system capable of serving about three million people through its outpatient facilities and eight member hospitals.

Rush University Medical Center

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to